Here are five highlights:
1. The appointment is for two years.
2. Mr. Flanagan possesses 30-plus years of medical device industry experience.
3. He is the CEO and board of directors’ chairman of DiscGenics, a regenerative medicine company for spine degenerative diseases.
4. Mr. Flanagan also founded Flanagan Instruments, a neurosurgical device distribution company. Itochu International purchased the company in 2005.
5. He serves on the boards of TrueVision Systems and Alliance for Regenerative Medicine.
More articles on spine:
5 key points on cost-effectiveness of perioperative thoracolumbar fracture imaging
Why Dr. Thomas Schuler says arthroplasty, artificial intelligence are the top 2 areas in spine surgery
Essentia Health-Duluth Clinic welcomes spine surgeon Dr. Anne Normand: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
